[Group B Streptococcus and High Level Resistance to Aminoglycosides: Therapeutic Implications for Neonates]

Arch Pediatr. 2003 Aug;10(8):736-7. doi: 10.1016/s0929-693x(03)00344-0.
[Article in French]

Publication types

  • Letter

MeSH terms

  • Aminoglycosides
  • Anti-Bacterial Agents / pharmacology*
  • Drug Resistance, Microbial
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases
  • Prevalence
  • Streptococcal Infections / drug therapy*
  • Streptococcus agalactiae / drug effects*
  • Streptococcus agalactiae / pathogenicity*

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents